These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 369138)

  • 41. [The etiological structure of dysentery in the city of Yerevan based on bacteriological and immunological studies].
    Chilingarian AV; Tatevosian AV; Avdeeva TA
    Zh Eksp Klin Med; 1972; 12(3):63-8. PubMed ID: 4573289
    [No Abstract]   [Full Text] [Related]  

  • 42. [Safety, reactivity and effectiveness testing of live shigella flexneri vaccines in laboratory animals and children (author's transl)].
    Sergeev VV; Elkina SI; Solodnikov YP; Shuster BY; Sergeeva GS; Bulk VF; Bobkin SV
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):121-8. PubMed ID: 4216247
    [No Abstract]   [Full Text] [Related]  

  • 43. [Use of the fluorescent antibody method for establishing the etiology of discrete outbreaks of dysentery].
    Pavlovich SI
    Pediatr Akus Ginekol; 1978; (5):29-30. PubMed ID: 362355
    [No Abstract]   [Full Text] [Related]  

  • 44. Serum enterotoxin-neutralizing antibody in human shigellosis.
    Keusch GT; Jacewicz M
    Nat New Biol; 1973 Jan; 241(105):31-2. PubMed ID: 4572837
    [No Abstract]   [Full Text] [Related]  

  • 45. Shigellosis in custodial institutions. 3. Prospective clinical and bacteriologic surveillance of children vaccinated with oral attenuated shigella vaccines.
    Levine MM; Gangarosa EJ; Werner M; Morris GK
    J Pediatr; 1974 Jun; 84(6):803-6. PubMed ID: 4596999
    [No Abstract]   [Full Text] [Related]  

  • 46. [Specific antigens of the causative agents and their antibodies in the circulating immune complexes in acute dysentery].
    Bunin KV; Iusova GA; Kravtsov EG; Belaia OF; Vaĭsbord NG
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Aug; (8):78-80. PubMed ID: 2414952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antibodies to enteropathogenic bacteria in the saliva of patients with different forms of acute intestinal diseases and healthy subjects].
    Gennad'eva TIa; Nikolaeva TA; Khazenson LB
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1976; 44():110-7. PubMed ID: 799368
    [No Abstract]   [Full Text] [Related]  

  • 48. [New methodological approaches to the use of the PHA reaction in determining anti-Shigella antibodies].
    Kaplin VN; Koriukina IP; Shliapnikova LN; Shalgina LV; Luzina GI; Dvorianskaia SV; Kuznetsov VF; Iurganova GA
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):79-83. PubMed ID: 7778383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immune globulins in children with Sonne dysentery].
    Korshunov MF
    Vopr Okhr Materin Det; 1972 Oct; 17(10):84. PubMed ID: 4571020
    [No Abstract]   [Full Text] [Related]  

  • 50. [Prevention of bacillary dysentery using a live anti-dysentery vaccine in a group of neuropsychopathic children].
    Meitert T; Istrati G; Sulea IT; Baron E; Andronescu C; Gogulescu L; Templea C; Ianopol L; Galan L; Fleşeriu M; Onciu C; Bogos L; Lupovici R; Boghiţoiu G; Ohmt E; Popescu G; Mihailiuc I; Maftei S; Tapu T; Zebreniuc D
    Arch Roum Pathol Exp Microbiol; 1973 Mar; 32(1):35-44. PubMed ID: 4585403
    [No Abstract]   [Full Text] [Related]  

  • 51. [Detection of Salmonella antigens in the neutralization reaction (ANR)].
    D'iachenko PN; Karagulova ST; Matveeva GE; Idrisova FR
    Zdravookhr Kirg; 1977; (2):34-9. PubMed ID: 17975
    [No Abstract]   [Full Text] [Related]  

  • 52. Future needs and directions for Shigella vaccines.
    Wkly Epidemiol Rec; 2006 Feb; 81(6):51-8. PubMed ID: 16673461
    [No Abstract]   [Full Text] [Related]  

  • 53. [Use of prodigiozan for increasing the effectiveness of the antibiotic therapy of dysentery in children].
    Vereshchagin IA; Zhuravleva OD
    Antibiotiki; 1984 Oct; 29(10):791-4. PubMed ID: 6439109
    [No Abstract]   [Full Text] [Related]  

  • 54. [Prodigiosin in the overall therapy of dysentery and in the prevention of intrahospital viral respiratory infection in children].
    Zlatkovskaia NM; Kleĭmenova IS; Evdoshenko VG; Zelenaia SN; Fuger NM
    Antibiotiki; 1975 Apr; 20(4):365-9. PubMed ID: 1108774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Study of intestinal infections in experiments on monkeys].
    Dzhikidze EK; Kavtaradze KN; Stasilevich ZK; Shaginian SA; Gvazava IS
    Vestn Akad Med Nauk SSSR; 1977; (8):59-65. PubMed ID: 410189
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
    Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
    [No Abstract]   [Full Text] [Related]  

  • 57. [The significance of the O antigen for the diagnosis of acute Sonne dysentery].
    Ivanov KS; Poliakov SV; Sboĭchakov VB; Semenova IA; Sakal' NN
    Vrach Delo; 1990 May; (5):106-8. PubMed ID: 1697713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Antibody against Shigella in bacillary dysentery patients and carriers. I. Sonne-dysentery].
    Miyata Y; Kitaura T; Hirakata T; Kakamura M; Sugiyama S
    Nihon Densenbyo Gakkai Zasshi; 1969 Dec; 43(9):217-24. PubMed ID: 4983206
    [No Abstract]   [Full Text] [Related]  

  • 59. [Bacillary dysentery--1990].
    Stypułkowska-Misiurewicz H; Adonajło A
    Przegl Epidemiol; 1992; 46(1-2):77-82. PubMed ID: 1475396
    [No Abstract]   [Full Text] [Related]  

  • 60. Assessment of antibody screening in selection of subjects for field trials of Shigella vaccines.
    Cohen D; Green MS; Block C; Rouach T; Ofek I; Swartz T; Lowell G; Tramont E
    Ann Sclavo Collana Monogr; 1986; 3(1-2):151-4. PubMed ID: 3322338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.